FDA Approves Canakinumab for Gout Flares
The US Food and Drug Administration (FDA) has approved canakinumab (Ilaris) for the treatment of gout flares in…
View Resource
Systemic Score Predicts Still's Disease Severe Complications
A multinational study of adults with Still’s disease found that calculating their systemic score…
View Resource
Lung Involvement in Still's Disease
A multicentre registry observational study assessed lung involvement in a cohort of Still’s disease…
View Resource
ACR20 – Autoinflammatory & Still's Disease Panel
This podcast features a discussion of autoinflammatory and Still’s disease abstracts from virtual ACR…
View Resource
Treatment Options for Still's Disease
Begin – are you treating “systemic” or “articular” (arthritis) Still’s disease? Most Still’s patients…
View Resource
Sleep Apnea Smart Watches (10.13.2023)
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past…
View Resource
Pharmacologic Efficacy in Still's Disease
A systematic review of the effectiveness and safety of pharmacological treatments for adult-onset Still’s…
View Resource
Weak Data (1.24.2025)
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. He features Dr.…
View Resource
When to Stop Biologics in Systemic JIA?
Systemic onset juvenile idiopathic arthritis (sJIA) is a dramatic onset inflammatory condition marked by…
View Resource
Undifferentiated Autoinflammatory Syndrome Called VEXAS
Saturday’s session on autoinflammatory syndromes featured Dr. Dan Kastner addressing – The Adult with…
View Resource